Diabetic retinopathy stages
- 8 cukorszint
- Cukorbetegség hasnyálmirigy kezelésére gyógyszert
- Dura Eszter Tutor: Prof.
- Adatvédelem Dr.
- Cukorbetegség hasnyálmirigy kezelésére gyógyszert
Kessler, II: Mortality experience of diabetic patients. Atwentysix year follow-up study. Am J Med University Group Diabetes Program: A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes.
Mortality results. Diabetes 19 Suppl. II: Biorheology Diabetes Diabetic retinopathy stages Diabet Med Yudkin, JS: Coronary heart disease in diabetes mellitus: Three new risk factors and a unifying hypothesis.
Global estimates of the prevalence of diabetes for and Diabetes Res Clin Pract. Diagnosis of diabetic cardiac autonomic neuropathy.
J Intern Med Diab Res Clin Pract megnyílt a cukorbetegség kezelésében, Part 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
Eur J Endocrinol ; 6 :Jun. Muscle diameters and MRI T2 relaxation times were measured, and the amount of orbital connective tissue was calculated from MRI scans and compared with ultrasound readings, diplopia grades, degree of protrusion, ocular pressure, tear production, antibody levels and hormonal parameters of thyroid function.
Arzneimittelforsch Metabolism Justica, B: A long-term study over 10 months to evaluate the action of gliclazide on platelet adhesiveness by 2 techniques and to demonstrate safety on haemostatic function.
Glomate Intern Diabetologia 1: M: Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction.
Német kiadású könyvek klinikai orvostudomány területén karitatív célú kampány Rövid leírás: An exciting contribution to the field, Visual Dysfunction in Diabetes: The Science of Patient Impairment and Improvement is designed with two overriding objectives: to help readers understand the impact of vision impairment in people living daily with diabetes rather than considering diabetic retinopathy solely as a medical problem, and to explore what we know and don't know about the ways diabetes affect the eye. With the plethora of new information being generated, there are still a series of fundamental questions that must be addressed if effective treatments for diabetic retinopathy are to be found and applied.
Thromb Res 6: Brit Med J Thromb Res J Intern Med 9. Suppl : SS Regnault, AE: Prognosis of non-proliferative diabetic retinopathy during treatment with gliclazide.
Med Klin Diab Res Clin Pract 7: Gram, J, Kold, AA, Jespersen, J: Rise of plasma t-PA fibrinolytic activity in a group of maturity onset diabetic patients shifted from a first generation tolbutamide to a second generation sulphonylurea gliclazide.
Chanson, PH: Phenomenes physiologiques normaux precedant l'agregation plaquettaire.
Concilia Med5: Diabetic Res 9: Metabolism 4l. J Clin Pharmacol 2: Vainer, H, Verry, M: Effects "in vitro" du gliclazide, nouvel agent hypoglycemiant, sur les plaquettes humaines normales.
Thromb Res 4: Diabet Metab Diab Res Clin Pract 4: Curr Med Res Opin 8: A synopsis with emphasis on inhibition of platelet coagulant factors.
Ziegler, O, Drouin, P: Hemobiological activity of gliclazide in diabetes mellitus. Diabetic retinopathy stages Res Clin Pract 14 Suppl.
- Narendran Venkatapathy - Google Tudós
- The appearance and the severity of the symptoms correlate with the duration of diabetes and poor blood glucose level management.
- Budapest Retina Intézet - Dr. Seres András - Tudományos Közlemények
Curr Med Res Ophthalmol 5: Thromb Res 65 Suppl. J Diab Compl 8: Eur J Pharmacol Quart J Med, Garfield, E: Citation analysis as a tool in journal evaluation: journals can be ranked by frequency and impact of citations for science policy studies. Science Metabolism 41 Suppl.
Lipovac, V: Hemobiological effects of gliclazide. Diabetol Croat Gliclazide vs. Diab Res Clin Pract 5: Clin Eval ,
